Johnson and Johnson International
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$119Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
652clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Ethicon $7,634 associated (2023-2025)
- Harmonic $6,292 associated (2023-2025)
- Dermabond Prineo $5,342 associated (2023-2025)
- Carto 3 $4,973 associated (2023-2025)
- Echelon Flex $3,567 associated (2023-2025)
- Stratafix $3,210 associated (2023-2025)
- Acuvue $3,150 associated (2023-2025)
- Dermabond $3,024 associated (2023-2025)
- Surgicel Nu-Knit $2,977 associated (2023-2025)
- Enseal $2,878 associated (2023-2025)
- Megadyne $2,697 associated (2023-2025)
- Enseal X1 $2,673 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Edgar Davila | San Juan, PR | Low Vision Rehabilitation | $7,417.91 |
| Ana Santos | Cayey, PR | Surgery | $6,640.54 |
| Pedro Gorbea Landron | San Juan, PR | Optometrist | $3,291.19 |
| Pedro Escobar Rodriguez | San Juan, PR | Gynecologic Oncology | $2,834.44 |
| Ariel Bermudez | Bayamon, PR | Surgery | $2,759.19 |
| Wanda Sangiovanni-Almonte | San Juan, PR | Optometrist | $2,394.66 |
| Marcia Alayon Rosario | Ponce, PR | Surgery | $2,085.34 |
| Jason Pingel | Mission, KS | Optometrist | $2,025.00 |
| Fernando Martinez Colon | Hato Rey, PR | Colon & Rectal Surgery | $1,662.48 |
| Carmen Casablanca Vazquez | Guaynabo, PR | Corneal and Contact Management | $1,549.02 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.